We create medical extended reality (MXR) apps at Cedars-Sinai using an iterative methodology. Our therapeutic software is rigorously developed and validated using a three-phase process, summarized below (read more):
VR1 studies focus on content development by working with patient and provider end-users through principles of human-centered design.
VR2 trials conduct early testing with a focus on feasibility, acceptability, tolerability, and initial clinical efficacy.
VR3 trials are randomized controlled trials that compare clinically important outcomes between intervention and control condition.
VR Solace was designed to distract people from pain and help them relax. Choose to virtually travel to one of eight beautiful and unique scenes. Along with soothing music and tranquil sound effects, unexpected delights keep things interesting and engaging. Watch the video, below, for a montage of scenes from VR Solace. We are currently testing this app in our NIH sponsored study of virtual reality for chronic GI cancer pain (read more).